Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association
It has been 50 years since Francis Fontan pioneered the operation that today bears his
name. Initially designed for patients with tricuspid atresia, this procedure is now offered for a …
name. Initially designed for patients with tricuspid atresia, this procedure is now offered for a …
Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital …
A Hernandez-Madrid, T Paul, D Abrams, PF Aziz… - EP …, 2018 - academic.oup.com
The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …
with more and more patients reaching adulthood. A significant portion of these young adults …
Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand
Y d'Udekem, AJ Iyengar, JC Galati, V Forsdick… - Circulation, 2014 - Am Heart Assoc
Background—The life expectancy of patients undergoing a Fontan procedure is unknown.
Methods and Results—Follow-up of all 1006 survivors of the 1089 patients who underwent a …
Methods and Results—Follow-up of all 1006 survivors of the 1089 patients who underwent a …
ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart …
Endorsed by the Association for European … - European heart …, 2010 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Hypoplastic left heart syndrome: current considerations and expectations
In the recent era, no congenital heart defect has undergone a more dramatic change in
diagnostic approach, management, and outcomes than hypoplastic left heart syndrome …
diagnostic approach, management, and outcomes than hypoplastic left heart syndrome …
Current therapy for hypoplastic left heart syndrome and related single ventricle lesions
RG Ohye, D Schranz, Y D'Udekem - Circulation, 2016 - Am Heart Assoc
Universally fatal only 4 decades ago, the progress in the 3-stage palliation of hypoplastic left
heart syndrome and related single right ventricular lesions has drastically improved the …
heart syndrome and related single right ventricular lesions has drastically improved the …
Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patients
GP Diller, A Giardini, K Dimopoulos… - European heart …, 2010 - academic.oup.com
Aims Previous studies have established an association between exercise intolerance and
increased morbidity and mortality in congenital heart disease patients. We aimed to clarify if …
increased morbidity and mortality in congenital heart disease patients. We aimed to clarify if …
Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover …
DJ Goldberg, B French, MG McBride, BS Marino… - Circulation, 2011 - Am Heart Assoc
Background—Children and young adults with single-ventricle physiology have abnormal
exercise capacity after the Fontan operation. A medication capable of decreasing pulmonary …
exercise capacity after the Fontan operation. A medication capable of decreasing pulmonary …
Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial
S Ishigami, S Ohtsuki, S Tarui, D Ousaka… - Circulation …, 2015 - Am Heart Assoc
Rationale: Hypoplastic left heart syndrome (HLHS) remains a lethal congenital cardiac
defect. Recent studies have suggested that intracoronary administration of autologous …
defect. Recent studies have suggested that intracoronary administration of autologous …
A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children
P Monagle, A Cochrane, R Roberts, C Manlhiot… - Journal of the American …, 2011 - jacc.org
Objectives: The purpose of this study was to compare the safety and efficacy of
acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure …
acetylsalicylic acid (ASA) and warfarin for thromboprophylaxis after the Fontan procedure …